| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.15 | 0.003 |